Suchergebnisse - "Hu, Yunping"

PubPharm (114)

1

A Dual Reversible Cross-Linked Hydrogel with Enhanced Mechanical Property and Capable of Proangiogenic and Osteogenic Activities for Bone Defect Repair

enthalten in: Macromolecular bioscience | 2024

von Chen, K. | He, W. | Gao, W. | +7

2

A Lactate-Depleting metal organic framework-based nanocatalyst reinforces intratumoral T cell response to boost anti-PD1 immunotherapy

enthalten in: Journal of colloid and interface science | 2024

von Zhou, J. | Hu, Y. | Cao, Y. | +8

3

An Immunocompetent Hafnium Oxide-Based STING Nanoagonist for Cancer Radio-immunotherapy

enthalten in: ACS nano | 2024

von Cao, Y. | Ding, S. | Hu, Y. | +10

4

EMP3 as a key downstream target of miR-663a regulation interferes with MAPK/ERK signaling pathway to inhibit gallbladder cancer progression

enthalten in: Cancer letters | 2023

von Ma, Q. | Zhang, Y. | Liang, H. | +8

5

A MOF-Based Potent Ferroptosis Inducer for Enhanced Radiotherapy of Triple Negative Breast Cancer

enthalten in: ACS nano | 2023

von Zeng, L. | Ding, S. | Cao, Y. | +10

6

YKL-40 derived from infiltrating macrophages cooperates with GDF15 to establish an immune suppressive microenvironment in gallbladder cancer

enthalten in: Cancer letters | 2023

von Wang, Z. | Wang, S. | Jia, Z. | +16

7

Virus-like particle-based delivery of Cas9/guide RNA ribonucleoprotein efficiently edits the brachyury gene and inhibits chordoma growth in vivo

enthalten in: Discover. Oncology | 2023

von Hu, Y. | Lu, B. | Deng, Z. | +2

8

An injectable and self-healing hydrogel with dual physical crosslinking for in-situ bone formation

enthalten in: Materials today. Bio | 2023

von Yu, T. | Hu, Y. | He, W. | +8

9

Cu(II)MXene based photothermal hydrogel with antioxidative and antibacterial properties for the infected wounds

enthalten in: Frontiers in bioengineering and biotechnology | 2023

von Liu, M. | Zheng, L. | Zha, K. | +9

10

Retraction notice to "EMP3, which is regulated by miR-663a, suppresses gallbladder cancer progression via interference with the MAPK/ERK pathway" [Canc. Lett. 430 (2018) 97-108

enthalten in: Cancer letters | 2022

von Ma, Q. | Zhang, Y. | Liang, H. | +8

RetractionOf: Cancer Lett. 2018 Aug 28;430:97-108. - PMID 29778567

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]